UBS AM’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.41M | Buy |
|
|||||
|
2024
Q3 | $947K | Sell |
|
|||||
|
2024
Q2 | $1.18M | Buy |
|
|||||
|
2024
Q1 | $579K | Hold |
|
|||||
|
2023
Q4 | $725K | Buy |
|
|||||
|
2023
Q3 | $530K | Hold |
|
|||||
|
2023
Q2 | $666K | Hold |
|
|||||
|
2023
Q1 | $666K | Sell |
|
|||||
|
2022
Q4 | $730K | Sell |
|
|||||
|
2022
Q3 | $734K | Hold |
|
|||||
|
2022
Q2 | $656K | Sell |
|
|||||
|
2022
Q1 | $715K | Buy |
|
|||||
|
2021
Q4 | $819K | Buy |
|
|||||
|
2021
Q3 | $477K | Buy |
|
|||||
|
2021
Q2 | $928K | Buy |
|
|||||
|
2021
Q1 | $1.24M | Hold |
|
|||||
|
2020
Q4 | $1.08M | Buy |
|
|||||
|
2020
Q3 | $642K | Hold |
|
|||||
|
2020
Q2 | $912K | Buy |
|
|||||
|
2020
Q1 | $781K | Buy |
|
|||||
|
2019
Q4 | $874K | Buy |
|
|||||
|
2019
Q3 | $523K | Buy |
|
|||||
|
2019
Q2 | $214K | Hold |
|
|||||
|
2019
Q1 | $298K | Sell |
|
|||||
|
2018
Q4 | $521K | Buy |
|
|||||
|
2018
Q3 | $564K | Buy |
|
|||||
|
2018
Q2 | $207K | Hold |
|
|||||
|
2018
Q1 | $221K | Sell |
|
|||||
|
2017
Q4 | $476K | Sell |
|
|||||
|
2017
Q3 | $822K | Buy |
|
|||||
|
2017
Q2 | $830K | Buy |
|
|||||
|
2017
Q1 | $247K | Hold |
|
|||||
|
2016
Q4 | $214K | Sell |
|
|||||
|
2016
Q3 | $436K | Hold |
|
|||||
|
2016
Q2 | $273K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $8.18M | Buy |
|
|||||
|
2014
Q4 | $3.49M | Buy |
|
|||||
|
2014
Q3 | $5.32M | Buy |
|
|||||
|
2014
Q2 | $7.04M | Buy |
|